PMID: 22210575

Riveline JP, Rousseau E, Reznik Y, Fetita S, Philippe J, Dechaume A, Hartemann A, Polak M, Petit C, Charpentier G, Gautier JF, Froguel P, Vaxillaire M
Clinical and metabolic features of adult-onset diabetes caused by ABCC8 mutations.
Diabetes Care. 2012 Feb;35(2):248-51. Epub 2011 Dec 30., [PubMed]
Sentences
No. Mutations Sentence Comment
38 ABCC8 p.Cys418Arg
X
ABCC8 p.Cys418Arg 22210575:38:106
status: NEW
view ABCC8 p.Cys418Arg details
ABCC8 p.Arg620Cys
X
ABCC8 p.Arg620Cys 22210575:38:129
status: NEW
view ABCC8 p.Arg620Cys details
ABCC8 p.Pro201Ser
X
ABCC8 p.Pro201Ser 22210575:38:219
status: NEW
view ABCC8 p.Pro201Ser details
Three mutations were previously reported (c.2476C.T/p.R826W in transient NDM [TNDM] (3,4,13), c.1252T.C/p.C418R and c.1858C.T/ p.R620C in congenital hyperinsulinism [CHI] (14,15)), and one mutation is novel (c.601C.G/p.P201S). Login to comment
40 ABCC8 p.Pro201Ser
X
ABCC8 p.Pro201Ser 22210575:40:4
status: NEW
view ABCC8 p.Pro201Ser details
The P201S mutation that lies at a highly conserved residue across mammalian species, in the L0-linker loop of the TMD0-L0 gatekeeper module of SUR1 (16),wasnotpresentin330normoglycemic French subjects. Login to comment
42 ABCC8 p.Cys418Arg
X
ABCC8 p.Cys418Arg 22210575:42:14
status: NEW
view ABCC8 p.Cys418Arg details
ABCC8 p.Arg620Cys
X
ABCC8 p.Arg620Cys 22210575:42:24
status: NEW
view ABCC8 p.Arg620Cys details
Genotyping of C418R and R620C mutations in .4,000 normoglycemic individuals from the French Data from an Epidemiological Study on the Insulin Resistance Syndrome (D.E.S.I.R.) cohort (18) identified five and one carrier, respectively, suggesting that they may represent rare variants (population carrier frequency of 0.06 and 0.012%) likely not related to disease. Login to comment
44 ABCC8 p.Cys435Arg
X
ABCC8 p.Cys435Arg 22210575:44:150
status: NEW
view ABCC8 p.Cys435Arg details
ABCC8 p.Cys418Arg
X
ABCC8 p.Cys418Arg 22210575:44:194
status: NEW
view ABCC8 p.Cys418Arg details
ABCC8 p.Tyr356Cys
X
ABCC8 p.Tyr356Cys 22210575:44:170
status: NEW
view ABCC8 p.Tyr356Cys details
ABCC8 p.Tyr356Cys
X
ABCC8 p.Tyr356Cys 22210575:44:176
status: NEW
view ABCC8 p.Tyr356Cys details
ABCC8 p.Tyr356Cys
X
ABCC8 p.Tyr356Cys 22210575:44:182
status: NEW
view ABCC8 p.Tyr356Cys details
ABCC8 p.Arg620Cys
X
ABCC8 p.Arg620Cys 22210575:44:200
status: NEW
view ABCC8 p.Arg620Cys details
ABCC8 p.Pro201Ser
X
ABCC8 p.Pro201Ser 22210575:44:188
status: NEW
view ABCC8 p.Pro201Ser details
1-II.1 2-II.1 3-II.1 3-II.2 4-II.1 4-III.1 4-III.2 D-1 D-2 D-3 D-4 Sex Female Male Male Male Male Female Male Female Male Male Female Mutation R1380H C435R L582 V L582 V Y356C Y356C Y356C P201S C418R R620C R826 W c.4139G.A c.1303T.C c.1744C.G c.1744C.G c.1067A.G c.1067A.G c.1067A.G c.601C.G c.1252T.C c.1858C.T c.2476C.T Previous report NDM (11) NDM (2) NDM (2) d Type 2 diabetes (7) d d None rs67254669* rs58241708* TNDM (4,6,13) Features at diagnosis or at ascertainment Status Diabetes Diabetes Diabetes Diabetes Diabetes Impaired glucose toleranceߤ Normal glucose toleranceߤ Type 2 diabetes Type 2 diabetes Type 2 diabetes Type 2 diabetes Age (years)/BMI (kg/m 2 ) 17/24 15/20 36/21 32/37 39/26 35/20 33/22 53/22 53/31 46/25 49/28 Symptoms Polyuria Polyuria None Obesity None None None Tiredness Hyperglycemia Polyuria None Features at last examination Age (years) 63 39 38 37 74 35 33 80 74 56 58 SU treatment 15 mg/day glyburidex 15 mg/day glyburidex 5 mg/day glyburide 160 mg/day gliclazide 3 mg/day glimepiride None None Glyburide| Glimepiride| Glypizide Glimepiride HbA 1c (%)ߥ 7.3 6.7 6.2 6.4 6.5 5.5 ND 7.4 6.2 6.8 6.2 C-peptide (pmol/mL) 0.08 0.14 ND ND 3.00 ND ND 1.17 2.08 1.90 3.80 All mutations were identified heterozygously in the patients. Login to comment
49 ABCC8 p.Leu582Val
X
ABCC8 p.Leu582Val 22210575:49:46
status: NEW
view ABCC8 p.Leu582Val details
ABCC8 p.Cys435Arg
X
ABCC8 p.Cys435Arg 22210575:49:39
status: NEW
view ABCC8 p.Cys435Arg details
A pathogenic role for three mutations (C435R, L582V, and R1380H) is very likely, because NDM was diagnosed in family relatives (this study) or reported by other studies (2,4,11). Login to comment
50 ABCC8 p.Tyr356Cys
X
ABCC8 p.Tyr356Cys 22210575:50:25
status: NEW
view ABCC8 p.Tyr356Cys details
The previously published Y356C and R826W mutations (4,6,7,13) were functionally demon- stratedtoalter MgATPsensitivityorATPase activity of SUR1, respectively, leading to KATP channel activation with increased resting whole-cell currents (7,13). Login to comment
51 ABCC8 p.Cys418Arg
X
ABCC8 p.Cys418Arg 22210575:51:42
status: NEW
view ABCC8 p.Cys418Arg details
ABCC8 p.Arg620Cys
X
ABCC8 p.Arg620Cys 22210575:51:52
status: NEW
view ABCC8 p.Arg620Cys details
We cannot exclude that two rare variants (C418R and R620C), as previously reported in CHI (14,15) and found here in two diabetic patients, are nonfunctional (i.e., nondeleterious). Login to comment
57 ABCC8 p.Leu582Val
X
ABCC8 p.Leu582Val 22210575:57:46
status: NEW
view ABCC8 p.Leu582Val details
ABCC8 p.Cys435Arg
X
ABCC8 p.Cys435Arg 22210575:57:39
status: NEW
view ABCC8 p.Cys435Arg details
A pathogenic role for three mutations (C435R, L582V, and R1380H) is very likely, because NDM was diagnosed in family relatives (this study) or reported by other studies (2,4,11). Login to comment
58 ABCC8 p.Tyr356Cys
X
ABCC8 p.Tyr356Cys 22210575:58:25
status: NEW
view ABCC8 p.Tyr356Cys details
The previously published Y356C and R826W mutations (4,6,7,13) were functionally demon- stratedtoalter MgATPsensitivityorATPase activity of SUR1, respectively, leading to KATP channel activation with increased resting whole-cell currents (7,13). Login to comment
59 ABCC8 p.Cys418Arg
X
ABCC8 p.Cys418Arg 22210575:59:42
status: NEW
view ABCC8 p.Cys418Arg details
ABCC8 p.Arg620Cys
X
ABCC8 p.Arg620Cys 22210575:59:52
status: NEW
view ABCC8 p.Arg620Cys details
We cannot exclude that two rare variants (C418R and R620C), as previously reported in CHI (14,15) and found here in two diabetic patients, are nonfunctional (i.e., nondeleterious). Login to comment